Researchers have discovered a new molecule that reduces hypersensitivity in mice when bound to a specific protein known to cause neuropathic pain. This revolutionary, non-opioid approach to pain management could be a game-changer for those who suffer from chronic neuropathic pain.
The study, conducted at the University of Texas and the University of Miami and published in the journal, Proceedings of the National Academy of Sciences, in December 2023 found that the molecular compound FEM-1689 effectively reduced neuropathic pain in mice with long-term results. Researchers hope to develop this compound into a drug to treat chronic neuropathic pain in humans without the dangerous side effects of opioids....
↧